Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies

Muscle and Nerve

Volumn 27, Issue 6, 2003, Pages 757-760

  Oh, Shin J ^a   Alapati, Anjaneyulu ^a   Claussen, Gwen C ^a   Vernino, Steven ^b  

^a The University of Alabama at Birmingham   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Dermatomyositis; Isaacs' syndrome; Myokymia; Neuromyotonia; Voltage gated K+ channel antibody

Indexed keywords

ANTICONVULSIVE AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; PHENYTOIN; POTASSIUM CHANNEL; PREDNISONE; STEROID;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; DERMATOMYOSITIS; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; FACE MUSCLE; FEMALE; HEMIFACIAL SPASM; HUMAN; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MOTOR UNIT POTENTIAL; MUSCLE DISEASE; MUSCLE STRENGTH; MUSCLE TWITCH; MYOKYMIA; MYOTONIA; NEEDLE ELECTROMYOGRAPHY; NERVE CONDUCTION; PRIORITY JOURNAL; RASH; SEIZURE; TREATMENT OUTCOME;

ACTION POTENTIALS; ADULT; AUTOANTIBODIES; CYCLOPHOSPHAMIDE; DERMATOMYOSITIS; FACIAL NERVE DISEASES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISAACS SYNDROME; METHYLPREDNISOLONE; MUSCLE, SKELETAL; PHENYTOIN; POTASSIUM CHANNELS, VOLTAGE-GATED; PREDNISONE; RECURRENCE;

EID: 0037532877     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.10369     Document Type: Article

References (17)

1. Albers JW, Allen AA, Bastron JA, Daube JR. Limb myokymia. Muscle Nerve 1981;4:494-504.
2. American Association of Electrodiagnostic Medicine. Glossary of terms in electrodiagnostic medicine. Muscle Nerve 2001; 24(suppl 10):S20.
3. + channel antibodies. Neurology 2000;54:771-772.
4. Gutmann L. Facial and limb myokymia. Muscle Nerve 1999; 14:1043-1049.
5. Gutmann L, Libell D, Gutmann L. When is myokymia neuromyotonia? Muscle Nerve 2001;24:151-153.
6. + channel antibodies. Neurology 2001;57:1707-1708.
7. Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, Morris C, Newsom-Davis J. Autoantibodies detected to expressed potassium channels are implicated in neuromyotonia. Ann Neurol 1997;41:238-246.
8. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002;125:1887-1895.
9. Heidenreich F, Vincent A. Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy. Neurology 1998;50:1483-1485.
10. Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, Baruzzi A, Carey T, Gambetti P, Lugaresi E, Montagna, P. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001;124:2417-2426.
11. Madisson P, Lawn N, Mills KR, Vincent A, Donaghy M. Acquired neuromyotonia in a patient with spinal epidural abscess. Muscle Nerve 1998;21:672-674.
12. Maddison P, Vincent A, Mills K, Davis CF. Persistent facial myokymia: an autoimmune aetiology. J Neurol 2000;247:554-555.
13. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Brain 1993;116:453-469.
14. Sinha S, Newsom-Davis J, Mills K, Byrne N, Lang B, Vincent A. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 1991;338:75-77.
15. + channels of peripheral nerves. Ann Neurol 1995;38:714-722.
16. Vernino S, Auger RG, Emslie-Smith AM, Harper CM, Lennon VA. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability. Neurology 1999; 53:1233-1239.
17. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 2002;26:702-707.